eanNews - Page 91 of 288 - Stay up to date with Neurology in Europe

- Executive Page: Multiple Opportunities to Serve & Support EAN & Neurology
  
  March 12, 2026
- President’s Corner – March 2026
  
  March 10, 2026
- Research Paper of the Month: Coffee and Tea Intake, Dementia Risk, and Cognitive Function
  
  March 2, 2026
- Executive Page: Building an Academic Path for Neurologists in Europe
  
  February 11, 2026
- President’s Corner – February 2026
  
  February 11, 2026
- Research Paper of the Month: Fremanezumab in Children and Adolescents with Episodic Migraine
  
  February 11, 2026

Top Articles

Calls for Coordinated Action on Brain Health in European Parliament on Brain Health Day

March 18, 2026

The European Parliament marked Brain Health Day: Prevention, Policy, Progress with a high‑level programme hosted by MEP Angelika Winzig, bringing renewed political attention to Europe’s urgent need for an integrated brain health strategy.

World’s largest brain research prize awarded for groundbreaking discoveries on how we sense touch and pain

March 6, 2026

12th Congress of the European Academy of Neurology celebrates with main headline that abstract submissions have hit record high!

EAN 2026 Hits New All-Time Abstract Submission Record

February 13, 2026

European Brain Health Summit 2026: Building the Foundation for a Brain-Healthy Society and Economy

February 12, 2026

Brain Health Day in white text on a blue-green gradient background

Join us for Brain Health Day: Prevention, Policy, Progress

February 11, 2026

Latest Posts

Breaking news COVID-19
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

July 1, 2021

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
Breaking news COVID-19
Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection

July 1, 2021

Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection
Breaking news COVID-19
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

July 1, 2021

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Breaking news COVID-19
The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

July 1, 2021

The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
Breaking news COVID-19
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis

July 1, 2021

Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Breaking news COVID-19
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

July 1, 2021

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Breaking news COVID-19
Increased transmissibility and global spread of SARSCoV-2 variants of concern as at June 2021

July 1, 2021

Increased transmissibility and global spread of SARSCoV-2 variants of concern as at June 2021
Fellowship reports Education corner
Clinical Fellowship Reports 2020

July 1, 2021

Two reports on Clinical Fellowships that took place in 2020
Breaking news COVID-19
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study

July 1, 2021

Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study
Breaking news COVID-19
Immunological imprinting of the antibody response in COVID-19 patients

July 1, 2021

Immunological imprinting of the antibody response in COVID-19 patients
Breaking news COVID-19
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

July 1, 2021

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Breaking news COVID-19
Dysregulation of brain and choroid plexus cell types in severe COVID-19

July 1, 2021

Dysregulation of brain and choroid plexus cell types in severe COVID-19
Breaking news COVID-19
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

July 1, 2021

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
Breaking news COVID-19
Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died

July 1, 2021

Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died
Breaking news COVID-19
Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19

July 1, 2021

Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19

Newer Posts

Older Posts